$60 Million Paid By GlaxoSmithKline To Settle Lawsuits Over Drug Avandia

Bloomberg Business Week reports the largest drug maker in the U.K., GlaxoSmithKline (Glaxo), has agreed to pay $60 million in the first settlements of lawsuits over their drug, Avandia. This diabetes drug has been cited as causing heart attacks and strokes in some of the users.